CompletedPhase 2NCT01104870

A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
United Therapeutics
Principal Investigator
Rajan Saggar, MD
UCLA Pulmonary Division
Intervention
UT-15C(drug)
Enrollment
50 enrolled
Eligibility
18-75 years · All sexes
Timeline
20102013

Study locations (9)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01104870 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials